These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9371338)

  • 1. Characterization of fluoroquinolone-induced Achilles tendon toxicity in rats: comparison of toxicities of 10 fluoroquinolones and effects of anti-inflammatory compounds.
    Kashida Y; Kato M
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2389-93. PubMed ID: 9371338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible involvement of nitric oxide in the quinolone-induced tendon lesions in rats.
    Kashida Y; Kato M
    Drugs Exp Clin Res; 1997; 23(3-4):139-43. PubMed ID: 9403275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological examination on Achilles tendon lesions induced by quinolone antibacterial agents in juvenile rats.
    Kato M; Takada S; Kashida Y; Nomura M
    Toxicol Pathol; 1995; 23(3):385-92. PubMed ID: 7659960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral toxicity of pefloxacin, norfloxacin, ofloxacin and ciprofloxacin: comparison of biomechanical and histopathological effects on Achilles tendon in rats.
    Olcay E; Beytemur O; Kaleagasioglu F; Gulmez T; Mutlu Z; Olgac V
    J Toxicol Sci; 2011 Jun; 36(3):339-45. PubMed ID: 21628961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pefloxacin-induced achilles tendon toxicity in rodents: biochemical changes in proteoglycan synthesis and oxidative damage to collagen.
    Simonin MA; Gegout-Pottie P; Minn A; Gillet P; Netter P; Terlain B
    Antimicrob Agents Chemother; 2000 Apr; 44(4):867-72. PubMed ID: 10722483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration].
    Fukuda H; Kawamura Y
    Jpn J Antibiot; 2002 Jun; 55(3):270-80. PubMed ID: 12199111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative comparison of the convulsive activity of combinations of twelve fluoroquinolones with five nonsteroidal antiinflammatory agents.
    Kim J; Ohtani H; Tsujimoto M; Sawada Y
    Drug Metab Pharmacokinet; 2009; 24(2):167-74. PubMed ID: 19430173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoroquinolone antimicrobials: singlet oxygen, superoxide and phototoxicity.
    Martínez LJ; Sik RH; Chignell CF
    Photochem Photobiol; 1998 Apr; 67(4):399-403. PubMed ID: 9559584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrastructural changes of the gemifloxacin on Achilles tendon in immature rats: comparison with those of ciproxacin and ofloxacin.
    Bae CS; Oh DM; Bae JG; Kim JC; Kim SH; Kim SG; Jeong MJ; Kim YS; Lim SC
    Basic Clin Pharmacol Toxicol; 2006 Apr; 98(4):406-10. PubMed ID: 16623866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructural changes induced by the des-F(6)-quinolone garenoxacin (BMS-284756) and two fluoroquinolones in Achilles tendon from immature rats.
    Shakibaei M; Stahlmann R
    Arch Toxicol; 2003 Sep; 77(9):521-6. PubMed ID: 12811465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens.
    Naber KG; Well M; Hollauer K; Kirchbauer D; Witte W
    Chemotherapy; 1998; 44(2):77-84. PubMed ID: 9551236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of the repeat dose toxicity of grepafloxacin and a number of other fluoroquinolones in rats.
    Takizawa T; Hasimoto K; Itoh N; Yamashita S; Owen K
    Hum Exp Toxicol; 1999 Jan; 18(1):38-45. PubMed ID: 10025367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructure of Achilles tendon from rats after treatment with fleroxacin.
    Shakibaei M; Stahlmann R
    Arch Toxicol; 2001 Apr; 75(2):97-102. PubMed ID: 11354912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risk of achilles tendon rupture with quinolone antibacterial use, especially in elderly patients taking oral corticosteroids.
    van der Linden PD; Sturkenboom MC; Herings RM; Leufkens HM; Rowlands S; Stricker BH
    Arch Intern Med; 2003 Aug 11-25; 163(15):1801-7. PubMed ID: 12912715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic effects of quinolone antibacterial agents on the musculoskeletal system in juvenile rats.
    Kashida Y; Kato M
    Toxicol Pathol; 1997; 25(6):635-43. PubMed ID: 9437810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative tolerability of the newer fluoroquinolone antibacterials.
    Ball P; Mandell L; Niki Y; Tillotson G
    Drug Saf; 1999 Nov; 21(5):407-21. PubMed ID: 10554054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial Achilles tendon ruptures associated with fluoroquinolone antibiotics: a case report and literature review.
    McGarvey WC; Singh D; Trevino SG
    Foot Ankle Int; 1996 Aug; 17(8):496-8. PubMed ID: 8863030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of renal function on the pharmacokinetics of lomefloxacin compared with other fluoroquinolones.
    Blum RA
    Am J Med; 1992 Apr; 92(4A):18S-21S. PubMed ID: 1316065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antimicrobial activity of fluoroquinolones against clinical isolates obtained in 1989 and 1990.
    Chen YC; Chang SC; Hsu LY; Hsieh WC; Luh KT
    J Formos Med Assoc; 1993 Dec; 92(12):1040-8. PubMed ID: 7911351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents.
    Barry AL; Jones RN
    J Antimicrob Chemother; 1989 Apr; 23(4):527-35. PubMed ID: 2745259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.